Beerse, Belgium

Albert Louis Willemsens



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1982-1998

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Albert Louis Willemsens: Innovator in Pharmaceutical Chemistry

Introduction

Albert Louis Willemsens is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of enantiomerically pure compounds. With a total of 4 patents to his name, Willemsens has established himself as a key figure in his industry.

Latest Patents

Willemsens' latest patents include a process for preparing enantiomerically pure 6-{4-chlorophenyl}(1H-1,2,4-triazol-1-yl)methyl-1-methyl-1H-benzotriazole. This innovative process involves the resolution of (±)-6-{(4-chlorophenyl)-hydrazinomethyl}-1-methyl-1H-benzotriazole and converting the appropriate enantiomerically pure hydrazine intermediate into the desired compound. His work in this area demonstrates his commitment to advancing pharmaceutical research.

Career Highlights

Willemsens has spent a significant portion of his career at Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work has contributed to the development of new medications and therapeutic solutions, showcasing his expertise and dedication to improving healthcare outcomes.

Collaborations

Throughout his career, Willemsens has collaborated with esteemed colleagues such as Guido J Van Der Veken and Walter Louis Verstappen. These partnerships have fostered innovation and have been instrumental in the successful development of various pharmaceutical products.

Conclusion

Albert Louis Willemsens is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His contributions, particularly in the area of enantiomerically pure compounds, highlight his importance as an innovator. His ongoing efforts continue to shape the future of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…